Profile for European Patent Office Patent: 1002795
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Lithuania | PA2008016 | ⤷ Start Trial |
| Denmark | CA 2009 00004 | ⤷ Start Trial |
| Netherlands | 300373 | ⤷ Start Trial |
| Luxembourg | 91528 | ⤷ Start Trial |
| Lithuania | PA2008016,C1002795 | ⤷ Start Trial |
| Ireland | SPC033/2008 | ⤷ Start Trial |
| France | 09C0004 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1002795
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
